Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Some people with Medicare could end up ...

Two new drug treatments prove effective in forestalling the start of early onset Alzheimer's; Roskamp will eventually offer ...

WASHINGTON--U.S. health officials on Friday approved a closely watched Alzheimer’s drug that’s been shown ... trouble remembering some student names and answering questions.

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

The 829 registered participants from 156 teams in Sunday's Walk to End Alzheimer's Northern Virginia, held at Reston Town ...

The European Medicines Agency’s human medicines committee is re-examining the marketing authorisation application for the ...

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold under the same brand name Kisunla. The Alzheimer's Association ...

After a dementia diagnosis, preparing key legal documents early helps families focus on the quality of life for their loved ...

In the ensuing years there have been countless near-misses with promising new drugs to treat Alzheimer's ... and Company and marketed under the brand name Kisunla. In July 2023, the FDA approved ...

(Reuters) - Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai and Biogen's ...